Lupus SLE Foundation
Data Collection & Internet Portals · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4997 Buckhannan Ave, Syracuse, New York,...Phone Number
(315) 434-0207Website
www.lupus-sle.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Lupus SLE Foundation
Spin and Win specializes in providing comprehensive reviews of online casinos, focusing on the gaming experience, safety, and enjoyment. The platform highlights various online gambling options, including features, games, and bonuses available at different casinos. It aims to guide thrill-seekers and gambling enthusiasts in finding reputable and secure online gaming environments. Spin and Win caters to clients looking for reliable information to enhance their online gaming adventures.Explore more
Lupus SLE Foundation Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lupus SLE Foundation your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Lupus SLE Foundation, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Lupus SLE Foundation had a recent Job posting/layoffs
Check if Lupus SLE Foundation has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Lupus SLE Foundation
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Lupus SLE Foundation recently announced quarterly report
Funding: Get notified immidiatlly once Lupus SLE Foundation has new funding data
Product Launch: Get notified when Lupus SLE Foundation launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Lupus SLE Foundation is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Lupus SLE Foundation as Masked Content
Find more new buyers
Compare Similar Companies to Lupus SLE Foundation
Compare insights from companies similar to Lupus SLE Foundation, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Lupus SLE Foundation is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
Lupus SLE Foundation is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about Lupus SLE Foundation.
Lupus SLE Foundation Tech Stack
A closer look at the technologies used by Lupus SLE Foundation
See more technologies
Lupus SLE Foundation News & Media
Saphnelo approved in EU for SLE
16 February 2022 07:00 GMT Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosus Saphnelo is a first-in-class type I interferon receptor antibody and the only new medicine in over a decade for patients with systemic lupus erythematosus AstraZeneca's Saphnelo (anifrolumab) has been approved in the European Union as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLESystemic Lupus Erythematosus Pipeline Insights | Research Report 2022 by DelveInsight
Systemic Lupus Erythematosus Pipeline involves 70+ key companies continuously working towards developing 70+ Systemic Lupus Erythematosus treatment therapies, as per DelveInsight Systemic Lupus Erythematosus Pipeline involves 70+ key companies continuously working towards developing 70+ Systemic Lupus Erythematosus treatment therapies, as per DelveInsightSaphnelo recommended for EU approval for SLE
20 December 2021 07:00 GMT Saphnelo recommended for approval in the EU by CHMP for the treatment of patients with systemic lupus erythematosus Saphnelo is a first-in-class type I interferon receptor antibody shown to reduce overall disease activity in patients with systemic lupus erythematosus AstraZeneca's Saphnelo (anifrolumab) has been recommended for marketing authorisation in the European Union (EU) as an add-on therapy for the treatment of adult patients with moderate to severe, active autSaphnelo approved in Japan for systemic lupus erythematosus
28 September 2021 07:00 BST Saphnelo approved in Japan for systemic lupus erythematosus Saphnelo is a first-in-class type I interferon receptor antibody shown to reduce overall disease activity in patients with systemic lupus erythematosus AstraZeneca's Saphnelo (anifrolumab) has been approved in Japan for the treatment of adult patients with systemic lupus erythematosus (SLE), a serious autoimmune disease, who show insufficient response to currently available treatment. The approval by the Japa
Read more news
Top Data Collection & Internet Portals Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lupus SLE Foundation
Sign Up For FreeTo access detailed company insights
Spin and Win specializes in providing comprehensive reviews of online casinos, focusing on the gaming experience, safety, and enjoyment. The platform highlights various online gambling options, including features, games, and bonuses available at different casinos. It aims to guide thrill-seekers and gambling enthusiasts in finding reputable and sec... Read More
